Clinical Approach to Wheezing
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of wheezing
Wheezing is one of the most common respiratory symptoms encountered in clinical practice, affecting approximately 25-30% of adults at some point in their lives. In emergency department settings, wheezing accounts for approximately 3-5% of all visits, with asthma exacerbations alone responsible for over 1.8 million emergency department visits annually in the United States. The symptom carries significant diagnostic weight, as it can represent conditions ranging from benign viral infections to life-threatening airway obstruction.
Definition
Wheezing is a continuous, high-pitched, musical sound produced by turbulent airflow through narrowed or compressed airways. It is most commonly heard during expiration but can occur during inspiration (or both phases) depending on the location and severity of airway obstruction. The characteristic musical quality distinguishes wheezing from other adventitious breath sounds such as crackles or stridor.
Key Epidemiology
- Asthma prevalence: Affects approximately 8% of adults worldwide, making it the most common cause of chronic wheezing
- Chronic obstructive pulmonary disease: Affects approximately 10% of adults over age 40; wheezing present in 60-70% of patients
- Acute bronchitis: Over 10 million cases annually in the United States, frequently presenting with transient wheezing
- Heart failure: Cardiac wheeze present in approximately 30% of acute decompensated heart failure cases
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 3 weeks | Viral respiratory infections, asthma exacerbations, acute bronchitis, anaphylaxis, foreign body aspiration | Often self-limiting; requires urgent evaluation if associated with respiratory distress or hypoxia |
| Subacute | 3 to 8 weeks | Post-infectious bronchial hyperreactivity, inadequately treated asthma, early chronic obstructive pulmonary disease presentation | May indicate transition to chronic condition; warrants systematic evaluation if not resolving |
| Chronic | Greater than 8 weeks | Asthma, chronic obstructive pulmonary disease, bronchiectasis, heart failure, endobronchial lesions | Requires comprehensive workup; underlying cause must be identified and treated |
Classification by Character
Polyphonic Wheeze
Description: Multiple musical notes occurring simultaneously, varying in pitch and timing
Mechanism: Widespread airway narrowing affecting multiple bronchi of varying caliber
Clinical implication: Suggests diffuse airway disease such as asthma or chronic obstructive pulmonary disease
Monophonic Wheeze
Description: Single musical note, constant pitch, often localized
Mechanism: Fixed obstruction in a single large airway
Clinical implication: Red flag for endobronchial lesion, foreign body, or extrinsic compression; requires urgent investigation
Classification by Timing in Respiratory Cycle
| Timing | Description | Suggests |
|---|---|---|
| Expiratory only | Wheeze heard during exhalation; most common pattern | Intrathoracic airway obstruction (asthma, chronic obstructive pulmonary disease); dynamic compression during expiration |
| Inspiratory only | Wheeze heard during inhalation; less common | Extrathoracic or fixed intrathoracic obstruction; may overlap with stridor if high-pitched |
| Biphasic (both phases) | Wheeze present during both inspiration and expiration | Severe airway obstruction or fixed lesion; indicates more significant narrowing |
| End-expiratory | Wheeze only at the terminal portion of exhalation | Mild airflow obstruction; earliest sign of bronchospasm |
Classification by Pattern and Triggers
| Pattern | Description | Suggests |
|---|---|---|
| Nocturnal predominance | Worse at night or early morning hours | Asthma (circadian variation in airway tone), gastroesophageal reflux disease, heart failure (recumbent position) |
| Exercise-induced | Triggered by physical exertion | Exercise-induced bronchoconstriction, cardiac disease, vocal cord dysfunction |
| Allergen-related | Occurs with specific exposures (dust, pollen, animals) | Allergic asthma, allergic rhinitis with lower airway involvement |
| Occupational | Improves on weekends and holidays; worsens at work | Occupational asthma, reactive airways dysfunction syndrome |
| Postprandial | Occurs after meals | Gastroesophageal reflux disease with aspiration, aspiration due to swallowing dysfunction |
| Position-dependent | Worse when lying flat | Heart failure (orthopnea), tracheomalacia, gastroesophageal reflux |
Key Concept — “All That Wheezes Is Not Asthma”: While asthma and chronic obstructive pulmonary disease account for the majority of wheezing in adults, the differential diagnosis is broad. Critical diagnoses not to miss include: (1) Anaphylaxis — life-threatening; (2) Acute heart failure — “cardiac asthma”; (3) Endobronchial obstruction — tumor, foreign body; (4) Pulmonary embolism — can present with focal wheezing. A monophonic, localized wheeze or wheezing that fails to respond to bronchodilators should prompt investigation for alternative diagnoses.
Clinical Impact and Quality of Life
Chronic wheezing significantly affects quality of life through multiple mechanisms: sleep disturbance (particularly with nocturnal symptoms), limitation of physical activity, work absenteeism, and psychological burden including anxiety about breathing. Studies show that patients with persistent wheezing report quality of life scores 15-25% lower than healthy controls. Early identification of the underlying cause and appropriate treatment can dramatically improve functional status and prevent disease progression.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of wheezing
Wheezing results from oscillation of airway walls when airflow becomes turbulent through narrowed segments. Understanding the physics of wheeze generation and the mechanisms by which various conditions cause airway narrowing is essential for accurate diagnosis and targeted treatment. The pitch of the wheeze is determined by the velocity of airflow and the mass and tension of the airway walls, while the location of narrowing determines whether the wheeze is localized or diffuse.
Physics of Wheeze Generation
| Component | Mechanism | Clinical Relevance |
|---|---|---|
| Airway narrowing | Reduces cross-sectional area, increasing flow velocity through the stenotic segment | Must achieve critical narrowing (typically greater than 50% reduction) to generate wheeze |
| Turbulent flow | Laminar flow becomes turbulent when velocity exceeds critical threshold (Reynolds number greater than 2000) | Very severe obstruction may paradoxically reduce wheeze as flow diminishes — “silent chest” |
| Airway wall oscillation | Turbulent flow causes flutter of airway walls, generating musical tones | Pitch correlates with wall tension and airflow velocity, not directly with airway size |
| Resonance | Downstream airways act as resonating chambers amplifying specific frequencies | Multiple airways of different sizes produce polyphonic wheeze; single airway produces monophonic wheeze |
Mechanisms of Airway Narrowing
Bronchospasm
Mechanism: Contraction of bronchial smooth muscle reducing airway diameter
Triggers: Allergens, irritants, cold air, exercise, parasympathetic activation
Clinical relevance: Rapidly reversible with bronchodilators; hallmark of asthma
Mucosal Edema
Mechanism: Inflammatory swelling of airway mucosa narrowing the lumen
Triggers: Infection, allergy, irritant exposure, inflammatory conditions
Clinical relevance: Responds to anti-inflammatory therapy; contributes to both acute and chronic conditions
Mucus Hypersecretion
Mechanism: Excess mucus production obstructing airway lumen
Triggers: Infection, chronic inflammation, irritant exposure
Clinical relevance: May be audible as coarse crackles along with wheeze; responds to mucolytics and airway clearance
Structural Remodeling
Mechanism: Chronic inflammation leads to fixed narrowing from fibrosis, smooth muscle hypertrophy
Conditions: Chronic asthma, chronic obstructive pulmonary disease
Clinical relevance: Irreversible component; poor response to bronchodilators
Dynamic Compression
Mechanism: Airways collapse during expiration when intrathoracic pressure exceeds intraluminal pressure
Conditions: Emphysema (loss of elastic recoil), tracheomalacia
Clinical relevance: Worse with forced expiration; may benefit from pursed-lip breathing or continuous positive airway pressure
Extrinsic Compression
Mechanism: External mass compressing airway from outside
Conditions: Lymphadenopathy, tumors, vascular anomalies, goiter
Clinical relevance: Fixed obstruction; monophonic wheeze; requires imaging for diagnosis
Location of Obstruction: Intrathoracic vs Extrathoracic
| Feature | Intrathoracic Obstruction | Extrathoracic Obstruction |
|---|---|---|
| Location | Below thoracic inlet (trachea, bronchi) | Above thoracic inlet (larynx, upper trachea) |
| Phase affected | Primarily expiratory (dynamic compression during expiration) | Primarily inspiratory (negative pressure collapses airway during inspiration) |
| Sound quality | Musical wheeze, often polyphonic | Stridor (harsh, high-pitched); may be monophonic wheeze |
| Common causes | Asthma, chronic obstructive pulmonary disease, endobronchial tumors | Vocal cord dysfunction, laryngeal edema, tracheal stenosis, goiter |
How Specific Conditions Cause Wheezing
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Asthma | Bronchospasm + mucosal edema + mucus hypersecretion; eosinophilic inflammation sensitizes smooth muscle to triggers | Bronchodilators provide rapid relief; inhaled corticosteroids address underlying inflammation |
| Chronic obstructive pulmonary disease | Fixed airway narrowing from structural remodeling + dynamic collapse from loss of elastic recoil (emphysema) + mucus hypersecretion (chronic bronchitis) | Bronchodilators help reversible component; limited response compared to asthma; smoking cessation essential |
| Acute heart failure (“cardiac asthma”) | Pulmonary edema causes peribronchial fluid accumulation and mucosal edema; bronchial venous congestion further narrows airways | Diuretics and afterload reduction more effective than bronchodilators; may coexist with true asthma |
| Anaphylaxis | Massive mast cell degranulation causes rapid bronchospasm + laryngeal edema + mucus secretion | Epinephrine is first-line; bronchodilators adjunctive; corticosteroids prevent biphasic reactions |
| Vocal cord dysfunction | Paradoxical adduction of vocal cords during inspiration (and sometimes expiration) creates functional obstruction | Does not respond to bronchodilators; speech therapy is primary treatment; recognize to avoid unnecessary asthma medications |
| Endobronchial tumor | Intraluminal mass causes fixed obstruction; may have associated mucus retention and inflammation | Bronchodilators ineffective; requires bronchoscopy for diagnosis; treatment depends on tumor type |
| Gastroesophageal reflux disease | Microaspiration causes direct airway irritation; vagal reflex from distal esophagus triggers bronchospasm | Proton pump inhibitors may reduce wheeze; often coexists with asthma |
| Foreign body aspiration | Physical obstruction of airway; may cause ball-valve effect with air trapping; secondary inflammation | Bronchoscopic removal required; unilateral wheeze is classic presentation |
Why Is Wheeze Predominantly Expiratory?
During expiration, positive intrathoracic pressure compresses intrathoracic airways, reducing their diameter. In healthy individuals, elastic recoil keeps airways open. However, in conditions with increased airway resistance or loss of elastic recoil, airways narrow or collapse during expiration, generating turbulent flow and wheeze. During inspiration, negative intrathoracic pressure tends to hold intrathoracic airways open, making inspiratory wheeze less common (unless obstruction is fixed or extrathoracic).
Often Overlooked Mechanism: Cardiac Asthma
Heart failure is frequently misdiagnosed as asthma or chronic obstructive pulmonary disease exacerbation. The mechanism involves peribronchial edema and bronchial mucosal congestion from elevated pulmonary venous pressure. Key distinguishing features include: orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, elevated jugular venous pressure, and S3 gallop. Brain natriuretic peptide (BNP) elevation supports cardiac etiology. These patients may have poor response to bronchodilators but improve dramatically with diuresis.
Critical Concept: The “Silent Chest”
Paradoxically, the most severe airway obstruction may present with absent breath sounds and no wheeze — the “silent chest.” This occurs because airflow is so severely reduced that it cannot generate the turbulence required for wheeze production. A patient in respiratory distress with diminished air entry and no wheeze is experiencing near-fatal bronchospasm and requires immediate intervention. The appearance of wheeze during treatment actually indicates improving airflow and is a positive sign.
3. History Taking
A comprehensive approach to eliciting the wheezing history
Red Flags — Require Urgent Evaluation
- Acute onset with urticaria, angioedema, or hypotension — Anaphylaxis
- Inability to speak in full sentences — Severe bronchospasm or impending respiratory failure
- Altered mental status or confusion — Hypoxia or hypercapnia
- Cyanosis — Severe hypoxemia
- Silent chest with respiratory distress — Near-fatal asthma or critical obstruction
- Stridor accompanying wheeze — Upper airway obstruction (anaphylaxis, epiglottitis, foreign body)
- New unilateral wheeze — Foreign body aspiration or endobronchial lesion
- Hemoptysis with wheezing — Malignancy, pulmonary embolism, or severe infection
- Sudden onset after choking episode — Foreign body aspiration
- Wheezing with chest pain and leg swelling — Pulmonary embolism
Systematic History: The “WHEEZE” Approach
Use the mnemonic “WHEEZE” to ensure comprehensive history taking:
- W — When and Where: When did it start? How long has it lasted? Where are you when it occurs (home, work, outdoors)?
- H — How does it sound and feel: Is it high-pitched or low? Continuous or intermittent? Associated with chest tightness or shortness of breath?
- E — Exacerbating and relieving factors: What makes it worse (exercise, cold air, allergens, position)? What makes it better (rest, inhalers, sitting upright)?
- E — Episodes and pattern: Is this the first episode or recurrent? Seasonal pattern? Nocturnal predominance? Relationship to meals?
- Z — Zones of exposure: Occupational exposures? Pets? Smoking (active or passive)? Recent travel? New home or workplace?
- E — Everything else: Associated symptoms (cough, sputum, fever, weight loss, reflux, leg swelling)? Past medical history? Medications? Family history of atopy?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Asthma | Episodic symptoms, triggers, personal or family history of atopy, nocturnal symptoms | “Do you have episodes where your breathing is normal between attacks? Does cold air or exercise trigger your symptoms? Do you have eczema or hay fever?” |
| Chronic obstructive pulmonary disease | Progressive dyspnea, smoking history, chronic productive cough | “How many pack-years have you smoked? Has your breathing gradually worsened over years? Do you cough up phlegm most days?” |
| Acute heart failure | Orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, known cardiac disease | “How many pillows do you sleep with? Do you wake up gasping for air at night? Have your ankles been swelling?” |
| Anaphylaxis | Acute onset after exposure, urticaria, angioedema, hypotension | “Did you eat anything new, take any medications, or get stung by an insect just before this started? Do you have hives or swelling of your lips or tongue?” |
| Gastroesophageal reflux disease | Postprandial symptoms, heartburn, regurgitation, nocturnal cough | “Is your wheeze worse after eating or when lying down? Do you have heartburn or a sour taste in your mouth?” |
| Vocal cord dysfunction | Inspiratory symptoms, throat tightness, sudden onset and resolution, poor response to inhalers | “Do you feel like your throat is closing rather than your chest? Does the wheeze seem to come from your throat? Does it resolve suddenly?” |
| Foreign body aspiration | Sudden onset during eating or with small objects, choking episode, unilateral symptoms | “Did this start suddenly while you were eating or putting something in your mouth? Did you have a choking episode?” |
| Occupational asthma | Symptoms improve on weekends and holidays, onset after starting new job or exposure | “Are your symptoms better on weekends or during holidays? Did this start after you began a new job or started working with new materials?” |
| Pulmonary embolism | Sudden onset, pleuritic chest pain, leg swelling, risk factors for venous thromboembolism | “Did the breathing difficulty come on suddenly? Do you have pain when you breathe deeply? Have you had recent surgery, prolonged immobility, or leg swelling?” |
| Endobronchial tumor | Progressive symptoms, hemoptysis, weight loss, smoking history, localized wheeze | “Have you coughed up any blood? Have you lost weight unintentionally? Is the wheeze always in the same spot?” |
Associated Symptoms to Explore
| Associated Symptom | Clinical Significance | Conditions to Consider |
|---|---|---|
| Productive cough with purulent sputum | Suggests infection or chronic bronchitis | Acute bronchitis, chronic obstructive pulmonary disease exacerbation, bronchiectasis, pneumonia |
| Dry cough | Suggests airway irritation without infection | Asthma, gastroesophageal reflux disease, angiotensin-converting enzyme inhibitor-induced cough, interstitial lung disease |
| Hemoptysis | Red flag requiring investigation | Lung cancer, pulmonary embolism, bronchiectasis, tuberculosis |
| Fever | Suggests infectious etiology | Acute bronchitis, pneumonia, influenza |
| Chest pain | Depends on character; pleuritic suggests pleural involvement | Pulmonary embolism, pneumonia, pneumothorax, musculoskeletal strain from coughing |
| Orthopnea and paroxysmal nocturnal dyspnea | Classic for cardiac etiology | Heart failure, severe gastroesophageal reflux disease |
| Peripheral edema | Suggests fluid overload or right heart failure | Heart failure, cor pulmonale from chronic lung disease |
| Weight loss | Red flag for malignancy or chronic disease | Lung cancer, tuberculosis, severe chronic obstructive pulmonary disease |
| Voice changes or hoarseness | Suggests laryngeal involvement | Vocal cord dysfunction, laryngeal tumor, recurrent laryngeal nerve palsy |
Medication and Social History
Medications That Cause or Worsen Wheezing
- Beta-blockers (including eye drops) — Block beta-2 receptors causing bronchoconstriction; can precipitate severe bronchospasm in asthmatics
- Aspirin and nonsteroidal anti-inflammatory drugs — Aspirin-exacerbated respiratory disease in susceptible individuals; affects approximately 7% of asthmatics
- Angiotensin-converting enzyme inhibitors — Can cause cough and occasionally bronchospasm via bradykinin accumulation
- Cholinergic agents — Increase bronchial secretions and smooth muscle tone
- Adenosine — Can trigger bronchospasm; use with caution in asthmatics
- Inhaled medications — Paradoxical bronchospasm from propellants or preservatives
Social and Occupational History
- Smoking: Pack-years calculation essential; includes cigarettes, cigars, pipes, marijuana, and vaping; secondhand smoke exposure
- Occupation: Bakers (flour), painters (isocyanates), healthcare workers (latex, cleaning agents), welders, farmers (organic dusts), hairdressers
- Home environment: Pets (especially cats, dogs), dust mites (carpeting, bedding), mold exposure, cockroach allergens, wood-burning stoves
- Hobbies: Woodworking, gardening, keeping birds
- Recent travel: Consider endemic infections (histoplasmosis, coccidioidomycosis)
- Drug use: Inhaled cocaine or heroin can cause bronchospasm
Past Medical and Family History
Past Medical History
- Previous asthma diagnosis: Age of onset, hospitalizations, intubations, steroid courses
- Atopic conditions: Eczema, allergic rhinitis, food allergies
- Cardiac disease: Heart failure, coronary artery disease, valvular disease
- Gastroesophageal reflux disease: Often undertreated contributor to wheezing
- Prior respiratory infections: Childhood respiratory syncytial virus, pertussis
- Surgical history: Recent anesthesia (postoperative atelectasis), recent surgery (pulmonary embolism risk)
Family History
- Asthma: Strong genetic component; first-degree relative increases risk 3-6 fold
- Atopy: Allergic rhinitis, eczema, food allergies in family
- Alpha-1 antitrypsin deficiency: Early-onset emphysema, liver disease
- Cystic fibrosis: If family history or clinical features suggest
- Lung cancer: Increases suspicion for malignancy in patient with risk factors
4. Physical Examination
A systematic head-to-toe approach for wheezing
Systematic Framework: Use the “General → Vital Signs → Head-to-Toe → Focused Respiratory” approach for complete examination of patients presenting with wheezing. The examination should assess both the severity of current respiratory compromise and provide clues to the underlying etiology.
Immediate Assessment: Is This Patient in Distress?
Signs of Severe Respiratory Compromise
- Inability to speak in full sentences — Indicates severe airflow limitation
- Tripod positioning — Patient sitting upright, leaning forward, hands on knees
- Accessory muscle use — Sternocleidomastoid, scalene, intercostal retraction
- Paradoxical abdominal breathing — Diaphragmatic fatigue; impending respiratory failure
- Silent chest — Absence of wheeze with diminished air entry; critical obstruction
- Altered mental status — Hypoxia or hypercapnia
- Cyanosis — Central cyanosis indicates severe hypoxemia (SpO2 typically less than 85%)
- Diaphoresis — Sign of respiratory distress and increased work of breathing
General Inspection
- Appearance: Comfortable or distressed? Able to speak in full sentences? Cachectic (chronic disease, malignancy) or obese (obstructive sleep apnea, obesity hypoventilation)?
- Position: Sitting upright (orthopnea suggests heart failure or severe asthma), tripod position (severe obstruction), unable to lie flat
- Respiratory effort: Respiratory rate, depth, use of accessory muscles, nasal flaring, pursed-lip breathing
- Color: Cyanosis (central vs peripheral), pallor, plethora (polycythemia from chronic hypoxia)
- Audible sounds: Wheeze audible without stethoscope suggests severe obstruction; stridor suggests upper airway involvement
- Skin: Urticaria or angioedema (anaphylaxis), eczema (atopy), nicotine staining
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C) | Suggests infection (acute bronchitis, pneumonia); absence does not exclude infection in elderly or immunocompromised |
| Heart Rate | Tachycardia (greater than 100 beats per minute) | Common in respiratory distress, fever, hypoxia; also beta-agonist effect; bradycardia in severe hypoxia is ominous |
| Blood Pressure | Hypotension, pulsus paradoxus | Hypotension suggests anaphylaxis or severe sepsis; pulsus paradoxus greater than 10 mmHg suggests severe asthma |
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute) | Sensitive marker of respiratory distress; normal rate does not exclude significant pathology |
| Oxygen Saturation | Hypoxemia (less than 94% on room air) | Indicates significant ventilation-perfusion mismatch; may be falsely normal in early disease or with supplemental oxygen |
| Peak Expiratory Flow | Less than 50% of predicted or personal best | Objective measure of airflow obstruction; useful for monitoring asthma severity and response to treatment |
How to Measure Pulsus Paradoxus
Pulsus paradoxus is an exaggerated fall in systolic blood pressure during inspiration (greater than 10 mmHg). To measure: inflate the blood pressure cuff above systolic pressure, then slowly deflate while the patient breathes normally. Note the pressure at which Korotkoff sounds are first heard (only during expiration), then continue deflating until sounds are heard throughout the respiratory cycle. The difference is the pulsus paradoxus. Values greater than 10 mmHg suggest severe asthma; greater than 25 mmHg indicates life-threatening attack.
Head and Neck Examination
Head and Face
- Nasal examination: Turbinate swelling, nasal polyps (aspirin-exacerbated respiratory disease, cystic fibrosis), deviated septum, purulent discharge (sinusitis)
- Oral cavity: Angioedema of lips or tongue (anaphylaxis), oral thrush (inhaled corticosteroid use), dental erosions (gastroesophageal reflux)
- Oropharynx: Cobblestoning (postnasal drip), erythema, tonsillar enlargement
- Eyes: Allergic shiners, conjunctival injection (allergy)
Neck
- Jugular venous pressure: Elevated in right heart failure, cor pulmonale, cardiac tamponade
- Thyroid: Goiter causing tracheal compression (rare cause of wheeze)
- Lymphadenopathy: Suggests infection, malignancy, or sarcoidosis
- Trachea: Deviation (tension pneumothorax, large pleural effusion, lung collapse); tracheal tug (severe airflow obstruction)
- Accessory muscle use: Sternocleidomastoid, scalene muscle contraction indicates increased work of breathing
Respiratory Examination
Inspection
- Chest shape: Barrel chest (hyperinflation from chronic obstructive pulmonary disease or chronic asthma), kyphoscoliosis (restrictive pattern)
- Symmetry: Asymmetric expansion suggests unilateral pathology (effusion, collapse, pneumothorax)
- Intercostal recession: Visible indrawing of intercostal spaces during inspiration indicates severe obstruction
- Subcostal recession: Diaphragmatic obstruction or fatigue
- Scars: Previous thoracic surgery, chest tube sites
Palpation
- Chest expansion: Reduced bilaterally in hyperinflation; asymmetrically reduced in unilateral pathology
- Tactile fremitus: Reduced in pleural effusion or pneumothorax; increased in consolidation
- Apex beat: Displaced in hyperinflation (down and to the right) or cardiomegaly (down and to the left)
- Subcutaneous emphysema: Crepitus suggests pneumothorax or pneumomediastinum
Percussion
- Hyperresonance: Air trapping (asthma, chronic obstructive pulmonary disease), pneumothorax
- Dullness: Consolidation, pleural effusion, lung collapse
- Decreased liver dullness: Hyperinflation pushing the liver down
- Cardiac dullness: May be obscured by hyperinflated lungs
Auscultation
| Finding | Description | Conditions |
|---|---|---|
| Polyphonic expiratory wheeze | Multiple musical pitches, bilateral, predominantly expiratory | Asthma, chronic obstructive pulmonary disease, acute bronchitis |
| Monophonic wheeze | Single constant pitch, often localized to one area | Endobronchial tumor, foreign body, mucus plug, extrinsic compression |
| Inspiratory wheeze | Wheeze during inspiration; may be monophonic | Fixed obstruction, vocal cord dysfunction (may sound like stridor) |
| Stridor | Harsh, high-pitched, predominantly inspiratory; heard over trachea | Upper airway obstruction: anaphylaxis, epiglottitis, foreign body, tracheal stenosis |
| Prolonged expiratory phase | Expiration takes longer than inspiration (normally I:E is 1:2; may be 1:4 or more) | Airflow obstruction from any cause |
| Diminished breath sounds | Reduced air entry bilaterally or unilaterally | Severe obstruction (silent chest), pleural effusion, pneumothorax, obesity |
| Fine crackles | Velcro-like, end-inspiratory, do not clear with cough | Interstitial lung disease, early pulmonary edema |
| Coarse crackles | Lower pitched, earlier in inspiration, may clear with cough | Secretions in larger airways, bronchiectasis, pulmonary edema |
Cardiovascular Examination
| Finding | Method | Significance |
|---|---|---|
| Elevated jugular venous pressure | Assess with patient at 45 degrees; measure height above sternal angle | Right heart failure, cor pulmonale, severe asthma (increased intrathoracic pressure) |
| Displaced apex beat | Palpate fifth intercostal space, mid-clavicular line | Cardiomegaly (heart failure), hyperinflation (displaced downward) |
| S3 gallop | Low-pitched sound after S2; best heard at apex with bell | Left ventricular failure; suggests cardiac cause of wheeze |
| Loud P2 | Compare pulmonary and aortic components of S2 | Pulmonary hypertension from chronic hypoxia |
| Murmurs | Auscultate all areas; note timing, radiation | Valvular disease (mitral stenosis can cause “cardiac asthma”) |
| Peripheral edema | Press over tibial area, sacrum if bedridden | Right heart failure, cor pulmonale |
Other Systems
Abdominal Examination
- Hepatomegaly: Passive congestion in right heart failure; may be pulsatile in tricuspid regurgitation
- Ascites: Severe right heart failure, hypoalbuminemia
- Hepatojugular reflux: Sustained jugular venous pressure rise with liver compression suggests heart failure
- Obesity: Associated with obstructive sleep apnea, obesity hypoventilation syndrome
Extremities
- Clubbing: Lung cancer, bronchiectasis, interstitial lung disease, cystic fibrosis; NOT seen in asthma or chronic obstructive pulmonary disease
- Cyanosis: Peripheral (cold extremities) vs central (hypoxemia)
- Edema: Bilateral suggests cardiac or systemic cause; unilateral suggests deep venous thrombosis (pulmonary embolism risk)
- Asterixis: Flapping tremor suggests hypercapnia
- Nicotine staining: Evidence of current smoking
Expected Findings by Etiology
| Condition | General | Respiratory | Other Findings |
|---|---|---|---|
| Acute asthma | Tachypnea, accessory muscle use, tripod position | Bilateral polyphonic wheeze, prolonged expiration, hyperresonance | Tachycardia, pulsus paradoxus; atopic features (eczema, rhinitis) |
| Chronic obstructive pulmonary disease | Barrel chest, pursed-lip breathing, cachexia | Decreased breath sounds, wheeze, prolonged expiration, hyperresonance | Nicotine staining, peripheral edema (cor pulmonale), clubbing absent |
| Heart failure | Orthopnea, tachypnea, diaphoresis | Bilateral basal crackles, wheeze (cardiac asthma) | Elevated jugular venous pressure, S3 gallop, peripheral edema, hepatomegaly |
| Anaphylaxis | Acute distress, anxiety, altered consciousness | Wheeze and/or stridor, respiratory distress | Urticaria, angioedema, hypotension, tachycardia |
| Pneumonia | Fever, tachypnea, unwell appearance | Focal crackles, bronchial breathing, localized wheeze possible | Fever, increased respiratory rate, may have pleural rub |
| Endobronchial tumor | Cachexia, weight loss, may appear well | Localized monophonic wheeze, may have collapse signs | Clubbing, lymphadenopathy, signs of metastases |
| Foreign body | Acute onset, may be well between episodes | Unilateral wheeze, asymmetric air entry | History of choking episode; often normal between attacks |
Important Teaching Point
Normal examination is possible! Patients with intermittent asthma, gastroesophageal reflux-associated wheeze, or vocal cord dysfunction may have completely normal physical examination findings between episodes. The absence of wheeze during examination does not exclude a diagnosis of asthma or other causes of episodic wheezing. Conversely, the “silent chest” in a distressed patient represents the most severe form of obstruction where airflow is too reduced to generate wheeze — this is a medical emergency.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute Wheezing (Duration: Less than 3 weeks)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 70%) | Asthma exacerbation | Known asthma history, identifiable trigger, bilateral polyphonic wheeze, responds to bronchodilators | Silent chest, inability to speak, altered consciousness, cyanosis |
| COMMON | Acute bronchitis | Viral prodrome, cough predominant, low-grade fever, self-limiting over 1-3 weeks | High fever, purulent sputum, focal findings (suggests pneumonia) |
| COMMON | Chronic obstructive pulmonary disease exacerbation | Known chronic obstructive pulmonary disease, increased dyspnea, sputum volume or purulence, smoking history | Severe hypoxia, hypercapnia, altered mental status |
| LESS COMMON (approximately 20%) | Acute decompensated heart failure | Orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, cardiac history, bilateral crackles | Hypotension, respiratory failure, acute pulmonary edema |
| LESS COMMON | Pneumonia with reactive airways | Fever, productive cough, focal examination findings, infiltrate on imaging | Sepsis, respiratory failure, multilobar involvement |
| LESS COMMON | Allergic reaction (without anaphylaxis) | Exposure history, urticaria, rhinitis, mild bronchospasm | Progression to anaphylaxis, angioedema, hypotension |
| UNCOMMON BUT SERIOUS (approximately 10%) | Anaphylaxis | Acute onset after exposure, urticaria, angioedema, hypotension, multisystem involvement | Rapidly progressive, airway compromise, cardiovascular collapse |
| UNCOMMON BUT SERIOUS | Pulmonary embolism | Sudden onset dyspnea, pleuritic chest pain, risk factors for venous thromboembolism, tachycardia | Hemodynamic instability, massive pulmonary embolism, right heart strain |
| UNCOMMON BUT SERIOUS | Foreign body aspiration | Sudden onset during eating or with small objects, unilateral wheeze, choking history | Complete obstruction, respiratory failure |
| UNCOMMON BUT SERIOUS | Pneumothorax | Sudden onset, pleuritic pain, reduced breath sounds unilaterally, hyperresonance | Tension pneumothorax (tracheal deviation, hypotension) |
Chronic Wheezing (Duration: Greater than 8 weeks)
Step-by-Step Approach to Chronic Wheezing:
- Step 1: Rule out obvious causes — Is the patient a smoker? On beta-blockers or angiotensin-converting enzyme inhibitors? Known cardiac disease?
- Step 2: Consider the “Big Three” causes — Asthma, chronic obstructive pulmonary disease, and heart failure account for the majority of chronic wheezing in adults
- Step 3: If initial workup negative, investigate for less common causes — Vocal cord dysfunction, gastroesophageal reflux disease, bronchiectasis, endobronchial lesions
- Step 4: Consider multiple overlapping etiologies — Many patients have more than one cause (e.g., asthma plus gastroesophageal reflux disease)
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Asthma | 30-40% | Episodic symptoms, triggers, nocturnal symptoms, atopy, reversible airflow obstruction, responds to inhaled corticosteroids |
| COMMON | Chronic obstructive pulmonary disease | 25-35% | Smoking history greater than 10 pack-years, progressive dyspnea, chronic cough, fixed airflow obstruction, age typically greater than 40 |
| COMMON | Asthma-chronic obstructive pulmonary disease overlap | 10-15% | Features of both conditions, significant smoking history with atopy or early-onset symptoms, partial bronchodilator reversibility |
| LESS COMMON | Chronic heart failure | 10-15% | Orthopnea, paroxysmal nocturnal dyspnea, edema, elevated brain natriuretic peptide, cardiac history, may coexist with lung disease |
| LESS COMMON | Gastroesophageal reflux disease | 5-10% | Postprandial symptoms, nocturnal cough, heartburn (may be absent), improves with proton pump inhibitor therapy |
| LESS COMMON | Vocal cord dysfunction | 3-5% | Inspiratory symptoms, throat tightness, sudden onset and resolution, poor response to bronchodilators, often misdiagnosed as refractory asthma |
| LESS COMMON | Bronchiectasis | 3-5% | Chronic productive cough with purulent sputum, recurrent infections, clubbing may be present, characteristic computed tomography findings |
| UNCOMMON | Endobronchial tumor | 1-3% | Localized monophonic wheeze, hemoptysis, weight loss, smoking history, does not respond to bronchodilators |
| UNCOMMON | Tracheobronchomalacia | 1-2% | Expiratory wheeze, barking cough, symptoms worse with forced expiration, often associated with chronic obstructive pulmonary disease |
| UNCOMMON | Eosinophilic bronchitis | 1-2% | Chronic cough, sputum eosinophilia, normal spirometry, responds to inhaled corticosteroids |
| UNCOMMON | Allergic bronchopulmonary aspergillosis | Less than 1% | Poorly controlled asthma, central bronchiectasis, elevated immunoglobulin E, positive Aspergillus serology |
| UNCOMMON | Carcinoid tumor | Less than 1% | Localized wheeze, recurrent pneumonia in same location, flushing and diarrhea (carcinoid syndrome) if metastatic |
Anatomical Approach to Wheezing
Upper Airway (Extrathoracic)
Vocal cord dysfunction
Laryngeal edema (anaphylaxis)
Laryngeal tumor
Tracheal stenosis
Goiter with tracheal compression
Epiglottitis
Central Airways (Intrathoracic)
Tracheobronchomalacia
Endobronchial tumor
Foreign body
Extrinsic compression (lymph nodes, tumor)
Tracheal stenosis (post-intubation)
Relapsing polychondritis
Lower Airways
Asthma
Chronic obstructive pulmonary disease
Acute bronchitis
Bronchiectasis
Eosinophilic bronchitis
Allergic bronchopulmonary aspergillosis
Extrapulmonary Causes
Heart failure (“cardiac asthma”)
Pulmonary embolism
Gastroesophageal reflux disease
Carcinoid syndrome
Systemic mastocytosis
Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis)
Drug-Induced Wheezing
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Beta-blockers (systemic) | Block beta-2 receptors on bronchial smooth muscle, preventing bronchodilation | Can precipitate severe bronchospasm in asthmatics; non-selective agents (propranolol) worse than selective (metoprolol) | Hours to days (depends on half-life) |
| Beta-blocker eye drops (timolol) | Systemic absorption through nasolacrimal duct; same mechanism as oral beta-blockers | Often overlooked cause; sufficient systemic absorption to cause bronchospasm | Days after discontinuation |
| Aspirin and nonsteroidal anti-inflammatory drugs | Inhibition of cyclooxygenase-1 shifts arachidonic acid metabolism toward leukotrienes | Aspirin-exacerbated respiratory disease: asthma, nasal polyps, aspirin sensitivity; affects approximately 7% of asthmatics | Hours; may have delayed reactions up to 24 hours |
| Angiotensin-converting enzyme inhibitors | Bradykinin accumulation; primarily causes cough but can worsen bronchospasm | Typically cough predominant; wheeze less common but reported | 1-4 weeks after discontinuation |
| Cholinesterase inhibitors | Increase acetylcholine at muscarinic receptors causing bronchoconstriction | Used in myasthenia gravis, Alzheimer disease; can precipitate bronchospasm | Hours to days |
| Adenosine | Direct bronchoconstriction via adenosine receptors on mast cells and smooth muscle | Used for supraventricular tachycardia; can cause severe bronchospasm in asthmatics | Minutes (very short half-life) |
| Inhaled medications (paradoxical reaction) | Reaction to propellants, preservatives (benzalkonium chloride), or cold aerosol | Paradoxical bronchospasm immediately after inhaler use | Minutes; switch to different formulation |
| Contrast media | Direct histamine release; anaphylactoid reaction | Occurs during or shortly after contrast administration | Minutes to hours; premedication for future studies |
| Antibiotics (penicillins, cephalosporins) | IgE-mediated allergic reaction | Part of allergic reaction spectrum; may progress to anaphylaxis | Variable; avoid future use |
| Inhaled pentamidine | Direct airway irritation | Used for Pneumocystis prophylaxis; common cause of bronchospasm | Hours; pretreat with bronchodilator |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Bilateral polyphonic wheeze + atopy + episodic | Asthma | Spirometry with bronchodilator reversibility testing |
| Wheeze + smoking history + chronic sputum | Chronic obstructive pulmonary disease | Spirometry showing fixed obstruction (FEV1/FVC less than 0.7) |
| Wheeze + orthopnea + peripheral edema | Heart failure | Brain natriuretic peptide, echocardiogram, chest radiograph |
| Acute wheeze + urticaria + hypotension | Anaphylaxis | Immediate epinephrine; identify and avoid trigger |
| Unilateral monophonic wheeze | Endobronchial lesion or foreign body | Chest computed tomography and bronchoscopy |
| Inspiratory wheeze/stridor + throat tightness | Vocal cord dysfunction | Laryngoscopy during symptoms |
| Wheeze worse after meals or lying flat | Gastroesophageal reflux disease | Empiric proton pump inhibitor trial; pH monitoring if no response |
| Wheeze + sudden onset + pleuritic pain + leg swelling | Pulmonary embolism | D-dimer, computed tomography pulmonary angiogram |
| Wheeze improves on weekends/holidays | Occupational asthma | Serial peak flow monitoring at work and away; specific inhalation challenge |
| Wheeze + hemoptysis + weight loss | Lung malignancy | Chest computed tomography, bronchoscopy |
| Wheeze + daily purulent sputum + clubbing | Bronchiectasis | High-resolution computed tomography of chest |
| Wheeze + nasal polyps + aspirin sensitivity | Aspirin-exacerbated respiratory disease | Avoid nonsteroidal anti-inflammatory drugs; consider aspirin desensitization |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Wheezing
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Pulse oximetry | Assess oxygenation; triage severity | SpO2 less than 94% indicates significant hypoxemia; less than 90% is severe | Immediate, noninvasive; does not assess ventilation (CO2); may be falsely normal early in disease |
| Peak expiratory flow | Objective measure of airflow obstruction | Less than 50% of predicted or personal best indicates severe obstruction | Effort-dependent; compare to predicted or patient’s personal best; useful for monitoring response to treatment |
| Chest radiograph | Exclude pneumonia, pneumothorax, heart failure, masses | Hyperinflation, infiltrates, cardiomegaly, pleural effusion, mass lesions | May be normal in asthma and chronic obstructive pulmonary disease; essential for excluding other causes |
| Electrocardiogram | Assess cardiac rhythm, ischemia, right heart strain | Arrhythmia, right axis deviation, P pulmonale, right ventricular hypertrophy, ischemic changes | Important if cardiac cause suspected or patient has cardiac risk factors |
| Complete blood count | Assess for infection, eosinophilia, anemia | Leukocytosis (infection), eosinophilia (greater than 300 cells/microL suggests allergic/eosinophilic disease), anemia (can worsen dyspnea) | Eosinophilia supports asthma, allergic bronchopulmonary aspergillosis, or eosinophilic conditions |
| Basic metabolic panel | Assess electrolytes, renal function | Electrolyte abnormalities (beta-agonist use causes hypokalemia), renal function for medication dosing | Important baseline before treatment; helps assess overall status |
Spirometry: The Cornerstone Investigation
Why Spirometry Is Essential
Spirometry is the gold standard for diagnosing and characterizing airflow obstruction. It should be performed in all patients with chronic wheezing once acute symptoms are controlled. Key measurements include forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and their ratio (FEV1/FVC).
| Finding | Definition | Interpretation |
|---|---|---|
| Obstructive pattern | FEV1/FVC less than 0.70 (or below lower limit of normal) | Asthma, chronic obstructive pulmonary disease, bronchiectasis, or other obstructive diseases |
| Bronchodilator reversibility | Improvement in FEV1 of 12% AND 200 mL after bronchodilator | Supports asthma diagnosis; partial reversibility may be seen in chronic obstructive pulmonary disease |
| Fixed obstruction | FEV1/FVC less than 0.70 without significant bronchodilator response | Suggests chronic obstructive pulmonary disease or fixed airway lesion |
| Normal spirometry | FEV1/FVC greater than or equal to 0.70, FEV1 greater than 80% predicted | Does not exclude asthma (may be normal between attacks); consider provocation testing if high clinical suspicion |
| Flow-volume loop abnormalities | Flattening of inspiratory or expiratory limb | Variable extrathoracic obstruction (inspiratory flattening), variable intrathoracic obstruction (expiratory flattening), fixed obstruction (both) |
Targeted Investigations by Suspected Etiology
If Suspecting Asthma
First-Line Tests
- Spirometry with bronchodilator: FEV1 improvement of 12% and 200 mL confirms reversibility
- Peak flow variability: Greater than 20% diurnal variation over 2 weeks supports asthma
- Fractional exhaled nitric oxide: Greater than 50 parts per billion in adults strongly supports eosinophilic airway inflammation
Second-Line Tests
- Methacholine challenge: PC20 less than 4 mg/mL is positive; high sensitivity (rules out asthma if negative)
- Allergy testing: Skin prick testing or specific IgE to identify triggers
- Sputum eosinophils: Greater than 3% supports eosinophilic asthma; guides biologic therapy
If Suspecting Chronic Obstructive Pulmonary Disease
First-Line Tests
- Post-bronchodilator spirometry: FEV1/FVC less than 0.70 confirms airflow obstruction
- Chest radiograph: Hyperinflation, flattened diaphragms, bullae; excludes other pathology
- Pulse oximetry: Baseline oxygen saturation; determines need for arterial blood gas
Second-Line Tests
- Alpha-1 antitrypsin level: All patients with chronic obstructive pulmonary disease, especially if young or non-smoker
- Computed tomography chest: Characterize emphysema distribution, exclude bronchiectasis or malignancy
- Arterial blood gas: If SpO2 less than 92% or acute exacerbation; assess for hypercapnia
- Echocardiogram: If suspecting pulmonary hypertension or cor pulmonale
If Suspecting Heart Failure
First-Line Tests
- Brain natriuretic peptide or N-terminal pro-brain natriuretic peptide: BNP greater than 100 pg/mL or NT-proBNP greater than 300 pg/mL supports heart failure
- Chest radiograph: Cardiomegaly, pulmonary venous congestion, pleural effusions, Kerley B lines
- Electrocardiogram: Left ventricular hypertrophy, atrial fibrillation, ischemic changes, conduction abnormalities
Second-Line Tests
- Echocardiogram: Assess left ventricular function (ejection fraction), valvular disease, diastolic dysfunction
- Troponin: If acute coronary syndrome suspected
- Thyroid function tests: Thyroid disease can cause or exacerbate heart failure
If Suspecting Endobronchial Lesion or Malignancy
First-Line Tests
- Computed tomography chest with contrast: Visualize airway lesions, masses, lymphadenopathy
- Sputum cytology: May identify malignant cells; low sensitivity but noninvasive
Second-Line Tests
- Bronchoscopy: Direct visualization and biopsy of endobronchial lesions
- Positron emission tomography-computed tomography: Staging if malignancy confirmed
- Endobronchial ultrasound: Sample mediastinal lymph nodes
If Suspecting Vocal Cord Dysfunction
First-Line Tests
- Spirometry with flow-volume loop: Flattening of inspiratory limb; variable extrathoracic obstruction pattern
- Laryngoscopy during symptoms: Gold standard; shows paradoxical vocal cord adduction during inspiration
Second-Line Tests
- Provocation laryngoscopy: Exercise or methacholine challenge with laryngoscopy if symptoms not present at rest
- Video recording: Document findings for patient education and treatment planning
If Suspecting Gastroesophageal Reflux Disease
First-Line Tests
- Empiric proton pump inhibitor trial: High-dose twice daily for 8-12 weeks; response supports diagnosis
Second-Line Tests
- 24-hour pH monitoring: Gold standard if empiric trial inconclusive; quantifies acid exposure
- Esophageal impedance monitoring: Detects non-acid reflux
- Upper endoscopy: If alarm symptoms (dysphagia, weight loss, anemia) or to evaluate for Barrett esophagus
Empiric Treatment Trials as Diagnostic Tools
Sequential Empiric Therapy Approach
When the diagnosis remains unclear after initial workup, empiric treatment trials can serve as diagnostic tools. Response to specific therapy supports the corresponding diagnosis. This approach is particularly useful for the “Big Three” causes of chronic cough with wheeze.
- Trial 1 — Inhaled corticosteroid plus bronchodilator: 4-8 weeks — tests for asthma and eosinophilic airway disease
- Trial 2 — Proton pump inhibitor (high-dose twice daily): 8-12 weeks — tests for gastroesophageal reflux disease
- Trial 3 — Intranasal corticosteroid plus antihistamine: 2-4 weeks — tests for upper airway contribution
- Trial 4 — Diuretic challenge: If cardiac wheeze suspected and diagnosis uncertain — response supports heart failure
When to Order Advanced Testing or Refer
| Clinical Situation | Recommended Test | Rationale |
|---|---|---|
| Wheezing not responding to standard asthma therapy | Computed tomography chest, bronchoscopy, laryngoscopy | Exclude structural lesion, vocal cord dysfunction, or alternative diagnosis |
| Localized or monophonic wheeze | Computed tomography chest, bronchoscopy | Evaluate for endobronchial tumor, foreign body, or extrinsic compression |
| Suspected severe or difficult asthma | Fractional exhaled nitric oxide, sputum eosinophils, total IgE, specific IgE panel | Phenotype asthma to guide biologic therapy selection |
| Young patient (less than 45 years) with chronic obstructive pulmonary disease features | Alpha-1 antitrypsin level and phenotype | Alpha-1 antitrypsin deficiency is treatable; family screening indicated if positive |
| Suspected occupational asthma | Serial peak flow monitoring, specific inhalation challenge testing | Confirm work-relatedness; significant medicolegal and occupational implications |
| Recurrent pneumonia in same location | Bronchoscopy with bronchoalveolar lavage | Evaluate for endobronchial obstruction, aspiration, or immunodeficiency |
Common Investigation Pitfalls
- Normal spirometry does not exclude asthma: Patients may be normal between attacks; consider methacholine challenge or serial peak flow monitoring
- Normal chest radiograph does not exclude significant pathology: Early malignancy, small foreign bodies, and most causes of wheeze have normal radiographs
- Relying on bronchodilator response alone: Some asthmatics show minimal acute reversibility; some chronic obstructive pulmonary disease patients show significant reversibility
- Not checking brain natriuretic peptide in elderly wheezers: Heart failure often mimics or coexists with chronic obstructive pulmonary disease
- Forgetting medication review: Beta-blockers (including eye drops) and nonsteroidal anti-inflammatory drugs are common overlooked causes
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Silent chest with respiratory distress, altered mental status, or cyanosis | EMERGENT | Prepare for intubation; continuous nebulized bronchodilators; intravenous corticosteroids; call for senior help immediately |
| Wheeze with urticaria, angioedema, or hypotension (anaphylaxis) | EMERGENT | Intramuscular epinephrine 0.3-0.5 mg immediately; establish intravenous access; prepare for airway management |
| Acute wheeze with stridor suggesting upper airway obstruction | EMERGENT | Keep patient calm and upright; prepare airway equipment; avoid agitating patient; call anesthesia/ENT |
| Severe asthma: cannot speak sentences, accessory muscle use, SpO2 less than 92% | URGENT | Continuous nebulized salbutamol; ipratropium bromide; intravenous corticosteroids; consider magnesium sulfate |
| Acute wheeze with fever, hypoxia, and focal chest findings | URGENT | Chest radiograph; blood cultures; start antibiotics for pneumonia; supplemental oxygen; bronchodilators |
| New wheeze with pleuritic chest pain and risk factors for venous thromboembolism | URGENT | D-dimer or computed tomography pulmonary angiogram based on clinical probability; anticoagulation if confirmed |
| Wheeze with orthopnea, peripheral edema, elevated jugular venous pressure | URGENT | Intravenous diuretics; oxygen; upright positioning; brain natriuretic peptide; echocardiogram; cardiology consultation |
| Mild wheeze, speaking in sentences, SpO2 greater than 94%, stable vital signs | ROUTINE | Inhaled bronchodilator; observe response; oral corticosteroids if asthma exacerbation; outpatient follow-up |
| Chronic intermittent wheeze, no red flags, stable between episodes | ROUTINE | Outpatient spirometry; trial of inhaled therapy; systematic workup for chronic wheeze |
Step 2: Classify by Duration
Acute (Less than 3 weeks)
Key questions:
- Is this a known asthmatic?
- Any anaphylaxis features?
- Signs of infection?
- Cardiac history?
Proceed to Algorithm A
Subacute (3-8 weeks)
Key questions:
- Post-infectious course?
- Medication changes?
- New exposures?
- Responding to treatment?
Proceed to Algorithm B
Chronic (Greater than 8 weeks)
Key questions:
- Smoking history?
- Atopic features?
- Cardiac symptoms?
- Red flags for malignancy?
Proceed to Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Wheezing
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Known asthmatic + identifiable trigger + bilateral wheeze + responds to bronchodilator | Asthma exacerbation | Bronchodilators, oral or intravenous corticosteroids based on severity; reassess peak flow; discharge planning |
| Smoking history + increased dyspnea and sputum + known chronic obstructive pulmonary disease | Chronic obstructive pulmonary disease exacerbation | Bronchodilators, systemic corticosteroids, antibiotics if purulent sputum; assess need for noninvasive ventilation |
| Viral prodrome + low-grade fever + cough + diffuse wheeze + no focal findings | Acute bronchitis | Supportive care; bronchodilators for symptom relief; antibiotics NOT indicated; expect resolution in 1-3 weeks |
| Recent allergen or drug exposure + urticaria + angioedema + hypotension | Anaphylaxis | Intramuscular epinephrine immediately; remove trigger; intravenous fluids; observe minimum 4-6 hours |
| Orthopnea + paroxysmal nocturnal dyspnea + edema + elevated jugular venous pressure + bilateral crackles | Acute heart failure | Intravenous diuretics; oxygen; upright positioning; brain natriuretic peptide; treat underlying cause |
| Sudden onset during eating + choking episode + unilateral wheeze | Foreign body aspiration | Chest radiograph (inspiratory and expiratory views); bronchoscopy for removal |
| Sudden onset + pleuritic pain + risk factors for venous thromboembolism + tachycardia | Pulmonary embolism | D-dimer if low probability; computed tomography pulmonary angiogram; anticoagulation if confirmed |
Algorithm B: Subacute Wheezing (3-8 weeks)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Post-viral illness + persistent cough and wheeze + normal chest radiograph | Post-infectious bronchial hyperreactivity | Trial of inhaled bronchodilator with or without inhaled corticosteroid; typically resolves over 4-8 weeks |
| Wheeze started after new medication (beta-blocker, nonsteroidal anti-inflammatory drug, angiotensin-converting enzyme inhibitor) | Drug-induced bronchospasm | Discontinue offending agent; substitute with alternative; reassess in 1-4 weeks |
| Episodic wheeze + triggers identified + family history of atopy | New-onset asthma | Spirometry with bronchodilator reversibility; trial of inhaled corticosteroid plus bronchodilator; allergy testing |
| Smoker + progressive symptoms + chronic sputum production | Chronic obstructive pulmonary disease (new diagnosis) | Spirometry; smoking cessation counseling; initiate appropriate inhaler therapy |
| Wheeze not responding to bronchodilators + localized or monophonic | Structural airway lesion | Computed tomography chest; bronchoscopy if abnormality identified or high clinical suspicion |
Algorithm C: Chronic Wheezing (Greater than 8 weeks)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Episodic symptoms + triggers + nocturnal symptoms + atopy + reversible obstruction | Asthma | Confirm with spirometry; step-up therapy as needed; identify and avoid triggers; asthma action plan |
| Smoking greater than 10 pack-years + age greater than 40 + fixed obstruction on spirometry | Chronic obstructive pulmonary disease | Smoking cessation is priority; inhaler therapy; pulmonary rehabilitation; vaccinations; assess for oxygen therapy |
| Features of both asthma and chronic obstructive pulmonary disease | Asthma-chronic obstructive pulmonary disease overlap | Treat with inhaled corticosteroid plus long-acting bronchodilators; monitor closely; avoid undertreating inflammation |
| Wheeze + orthopnea + edema + elevated brain natriuretic peptide + cardiomegaly | Heart failure with reactive airways | Optimize heart failure therapy; diuretics; echocardiogram; may still need bronchodilators for comfort |
| Wheeze worse after meals or supine + heartburn or regurgitation | Gastroesophageal reflux disease-related wheeze | High-dose proton pump inhibitor twice daily for 8-12 weeks; lifestyle modifications; pH monitoring if no response |
| Inspiratory symptoms + throat tightness + sudden resolution + poor inhaler response | Vocal cord dysfunction | Laryngoscopy during symptoms; speech therapy referral; breathing exercises; address underlying anxiety if present |
| Localized wheeze + hemoptysis + weight loss + smoking history | Endobronchial malignancy | Urgent computed tomography chest; bronchoscopy; staging workup; oncology referral |
| Chronic sputum production + recurrent infections + clubbing | Bronchiectasis | High-resolution computed tomography; sputum culture; airway clearance techniques; treat exacerbations promptly |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient on beta-blocker develops new wheeze | Discontinue beta-blocker (including eye drops); switch to alternative agent | Reassess in 1-2 weeks; if wheeze persists, investigate other causes |
| Asthma patient not responding to usual treatment | Reassess severity; check inhaler technique; consider nebulized therapy | Add ipratropium; consider intravenous magnesium; prepare for escalation if no improvement |
| Elderly patient with wheeze and leg swelling | Check brain natriuretic peptide; chest radiograph; consider diuretic trial | Echocardiogram; may have both chronic obstructive pulmonary disease and heart failure |
| Wheeze resolves completely between attacks | Document symptoms; provide peak flow meter for home monitoring | Arrange spirometry including provocation testing if baseline normal |
| Monophonic wheeze in the same location every time | Order computed tomography chest | Bronchoscopy if abnormality seen or high clinical suspicion despite normal computed tomography |
| Patient insists they have asthma but spirometry is normal | Check fractional exhaled nitric oxide; consider methacholine challenge | If negative, investigate vocal cord dysfunction, anxiety, or cardiac causes |
| Wheeze worse at work, better on holidays | Serial peak flow monitoring (at work and away from work for 2-4 weeks) | Occupational medicine referral; specific inhalation challenge if indicated |
| Severe asthmatic requiring frequent oral corticosteroids | Ensure adherence and correct technique; treat comorbidities (reflux, rhinitis) | Refer to specialist for phenotyping and consideration of biologic therapy |
Troubleshooting Refractory Wheezing
When Wheezing Does Not Respond to Treatment, Ask These Questions
- Is the diagnosis correct? — Consider vocal cord dysfunction, heart failure, structural lesion, or other mimics
- Is the patient using medications correctly? — Check inhaler technique; up to 90% of patients use inhalers incorrectly
- Is adherence adequate? — Ask non-judgmentally about missed doses; check prescription refill records
- Are there ongoing triggers? — Occupational exposures, pets, smoking (active or passive), allergens at home
- Are comorbidities undertreated? — Gastroesophageal reflux disease, rhinosinusitis, obesity, obstructive sleep apnea
- Are there multiple overlapping causes? — Many patients have more than one etiology (e.g., asthma plus reflux plus rhinitis)
- Is this severe or difficult-to-treat asthma? — Referral for specialist assessment and consideration of biologics
- Are there psychosocial factors? — Anxiety, depression, and stress can worsen symptoms and reduce adherence
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
All that wheezes is not asthma: Always consider heart failure, vocal cord dysfunction, endobronchial obstruction, and anaphylaxis in your differential. A monophonic, localized wheeze demands investigation for structural pathology.
The silent chest is the most dangerous chest: Absence of wheeze in a patient with respiratory distress indicates critically reduced airflow. This is near-fatal bronchospasm requiring immediate aggressive intervention. The return of wheeze during treatment is a positive sign.
Check the medication list — especially eye drops: Beta-blocker eye drops (timolol) are systemically absorbed and can trigger severe bronchospasm. Also review for nonsteroidal anti-inflammatory drugs, aspirin, and angiotensin-converting enzyme inhibitors.
Cardiac asthma is real and common: Heart failure causes wheeze through peribronchial edema. Clues include orthopnea, paroxysmal nocturnal dyspnea, elevated brain natriuretic peptide, and poor response to bronchodilators but good response to diuretics.
Normal spirometry does not exclude asthma: Patients with intermittent asthma often have normal lung function between attacks. If clinical suspicion is high, pursue methacholine challenge testing or serial peak flow monitoring.
Vocal cord dysfunction mimics asthma: Suspect when symptoms are inspiratory, localized to the throat, resolve suddenly, and do not respond to bronchodilators. Laryngoscopy during symptoms confirms the diagnosis. Treatment is speech therapy, not inhalers.
Multiple etiologies often coexist: A patient may have asthma exacerbated by gastroesophageal reflux disease and undertreated rhinosinusitis. Address all contributing factors for optimal control.
Inhaler technique matters more than inhaler choice: Up to 90% of patients use inhalers incorrectly. Always observe technique and correct errors. Consider spacer devices for metered-dose inhalers.
Critical Pitfalls to Avoid
Treating all wheeze as asthma without confirming the diagnosis: Empiric bronchodilator therapy is appropriate initially, but if response is incomplete or symptoms persist, systematically evaluate for alternative diagnoses.
Ignoring a localized or monophonic wheeze: This pattern suggests fixed obstruction from tumor, foreign body, or extrinsic compression. Always investigate with imaging and consider bronchoscopy.
Forgetting to ask about beta-blocker eye drops: Patients often do not consider eye drops as “medications.” Always specifically ask about glaucoma treatment. Timolol eye drops have caused fatal bronchospasm in asthmatics.
Reassured by absence of wheeze in a distressed patient: The silent chest indicates critically reduced airflow — not improvement. This patient needs urgent escalation, not reassurance.
Missing heart failure in elderly patients with “chronic obstructive pulmonary disease exacerbation”: Always check brain natriuretic peptide in older patients with wheeze. Heart failure and chronic obstructive pulmonary disease commonly coexist and require different treatments.
Delaying epinephrine in anaphylaxis: If anaphylaxis is suspected, give intramuscular epinephrine immediately. There is no contraindication to epinephrine when anaphylaxis is occurring. Delayed administration increases mortality.
Assuming normal chest radiograph excludes serious pathology: Many causes of wheeze, including asthma, early malignancy, pulmonary embolism, and foreign body, may have normal chest radiographs. Clinical suspicion should drive further investigation.
Labeling refractory symptoms as “non-compliance” without verifying technique: Before assuming non-adherence, always observe inhaler technique. Even educated patients make errors. Correct technique before escalating therapy.
Key Takeaways
- Wheeze is produced by turbulent airflow through narrowed airways; the pitch correlates with airflow velocity and wall tension, not directly with airway size.
- Classify wheezing by duration (acute, subacute, chronic), character (polyphonic versus monophonic), and timing (expiratory, inspiratory, biphasic) to narrow the differential.
- The “silent chest” paradox: the most severe obstruction produces no wheeze because airflow is too reduced to generate turbulence — this is a medical emergency.
- Asthma and chronic obstructive pulmonary disease are the most common causes of chronic wheeze, but always consider heart failure, gastroesophageal reflux disease, and vocal cord dysfunction.
- A monophonic, localized wheeze that does not change with bronchodilators suggests fixed structural obstruction and requires computed tomography and bronchoscopy.
- Drug-induced wheeze is common and often overlooked — specifically ask about beta-blockers (including eye drops), nonsteroidal anti-inflammatory drugs, and aspirin.
- Spirometry with bronchodilator reversibility testing is the cornerstone investigation for chronic wheeze; normal spirometry does not exclude asthma.
- Multiple etiologies commonly coexist — systematically address asthma, gastroesophageal reflux disease, rhinosinusitis, and any other contributing factors for optimal control.
- Inhaler technique errors are extremely common and should be corrected before escalating therapy or concluding that treatment has failed.
- In anaphylaxis, give intramuscular epinephrine immediately — there are no absolute contraindications when anaphylaxis is occurring.
Quick Reference Algorithm
Systematic Approach to the Wheezing Patient:
- Assess urgency: Is there respiratory distress, silent chest, anaphylaxis, or stridor? If yes, treat emergently while investigating.
- Classify by duration: Acute (less than 3 weeks), subacute (3-8 weeks), or chronic (greater than 8 weeks) — this guides differential diagnosis.
- Characterize the wheeze: Polyphonic (diffuse airways disease) versus monophonic (focal obstruction); expiratory (intrathoracic) versus inspiratory (extrathoracic or fixed).
- Take targeted history: Use the WHEEZE mnemonic; identify red flags; ask about medications (especially beta-blockers and nonsteroidal anti-inflammatory drugs).
- Perform focused examination: Assess severity; listen for wheeze character and distribution; look for signs of heart failure, anaphylaxis, or upper airway obstruction.
- Order appropriate investigations: Baseline tests for all (pulse oximetry, peak flow, chest radiograph); spirometry for chronic wheeze; targeted testing based on clinical suspicion.
- Initiate treatment based on most likely diagnosis: Bronchodilators for obstructive airways disease; diuretics for heart failure; epinephrine for anaphylaxis.
- Reassess response and reconsider diagnosis if treatment fails: Check technique and adherence; investigate for alternative or additional diagnoses; refer if refractory.